bortezomib - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
BORTEZOMIB ACCORD bortezomib 3.5 mg/1.4 mL solution for injection vial AUST R: 369472 Active ingredients: bortezomib Dosage form: Injection, solution Sponsor: Accord Healthcare Pty Ltd Phone: 1800 222 673	From 30 Apr 2025 to 31 Jul 2025	Shortage status: Current Availability: Unavailable Reason: Manufacturing Management action: Alternative generic products are available.
DBL BORTEZOMIB 2.5 mg powder for injection vial AUST R: 275710 Active ingredients: bortezomib Dosage form: Injection, powder for Sponsor: Pfizer Australia Pty Ltd Phone: 1800-675-229	Deletion from market: 01 Oct 2024	Shortage status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: An alternative product is available.
DBL Bortezomib bortezomib 1.0 mg powder for injection vial AUST R: 313359 Active ingredients: bortezomib Dosage form: Injection, powder for Sponsor: Pfizer Australia Pty Ltd Phone: 1800-675-229	Deletion from market: 01 Oct 2024	Shortage status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: An alternative product is available.
VELCADE bortezomib 3.5 mg powder for injection vial AUST R: 104542 Active ingredients: bortezomib Dosage form: Injection, powder for Sponsor: Janssen-Cilag Pty Ltd Phone: 1800226334	Deletion from market: 30 Jun 2025	Shortage status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: Alternative generic products are available.